Immunoassay Market Report by Technology (Radioimmunoassay, Enzyme Immunoassay, Rapid Test, and Others), Product (Reagents and Kits, Analyzers/Instruments, Software and Services), Application (Therapeutic Drug Monitoring, Oncology, Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, and Others), End Use (Hospitals, Blood Banks, Clinical Laboratories, Pharmaceutical and Biotech Companies, Academic Research Centers, and Others), and Region 2024-2032

Immunoassay Market Report by Technology (Radioimmunoassay, Enzyme Immunoassay, Rapid Test, and Others), Product (Reagents and Kits, Analyzers/Instruments, Software and Services), Application (Therapeutic Drug Monitoring, Oncology, Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, and Others), End Use (Hospitals, Blood Banks, Clinical Laboratories, Pharmaceutical and Biotech Companies, Academic Research Centers, and Others), and Region 2024-2032

Report Format: PDF+Excel | Report ID: SR112025A3753

Market Overview:

The global immunoassay market size reached US$ 31.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 49.5 Billion by 2032, exhibiting a growth rate (CAGR) of 5.2% during 2024-2032.

Report Attribute 
Key Statistics
Base Year
2023
Forecast Years
2024-2032
Historical Years
2018-2023
Market Size in 2023
US$ 31.0 Billion
Market Forecast in 2032
US$ 49.5 Billion
Market Growth Rate 2024-2032 5.2%


Immunoassay (IA) is a technique used to measure the concentration of analytes in a solution with an antibody or an antigen as a biorecognition agent. It plays a crucial role in clinical diagnostics, pharmaceutical analysis, environmental monitoring, and security. It is widely used in research centers, hospitals, and laboratories to diagnose different diseases and improve the overall health and well-being of humans and animals. Moreover, as it is fast, simple, and cost-effective, IA is rapidly replacing conventional tests, such as high-performance liquid chromatography (HPLC) and gas chromatography (GC), for on-site analysis of food contamination.

The escalating number of individuals suffering from chronic and infectious diseases represents one of the key factors propelling the market growth. As IA offers inherent specificity, high-throughput, and high sensitivity for the analysis of biological samples, it is used in disease diagnosis, therapeutic drug monitoring, clinical pharmacokinetics, and drug discovery around the world. Moreover, automation, versatility, and the speed of analysis, along with stringent regulatory framework regarding food safety, is influencing the demand for IA in food testing. Apart from this, researchers are developing prominent immunoanalytical systems, including surface plasmon resonance (SPR)-based instruments using bioengineering, microfluidic, and biosensor technologies. These systems help in the detection of analytes and the screening of immunological components based on biomolecular interactions. Furthermore, the emerging trend of smartphone-based formats and multiplex bead assays is anticipated to drive the demand for IAs for managing health complications in real-time and enabling in vitro diagnostics.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global immunoassay market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on technology, product, application and end use.

Breakup by Technology:

  • Radioimmunoassay
  • Enzyme Immunoassay
  • Rapid Test
  • Others
     

Breakup by Product:

  • Reagents and Kits
  • Analyzers/Instruments
  • Software and Services
     

Breakup by Application:

  • Therapeutic Drug Monitoring
  • Oncology
  • Cardiology
  • Endocrinology
  • Infectious Disease Testing
  • Autoimmune Diseases
  • Others
     

Breakup by End Use:

  • Hospitals
  • Blood Banks
  • Clinical Laboratories
  • Pharmaceutical and Biotech Companies
  • Academic Research Centers
  • Others
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott, Becton Dickinson and Company, BioMérieux SA, Danaher Corporation, Merck KGaA, PerkinElmer Inc, Quidel Corporation, Siemens Healthcare Pty Ltd (Siemens AG), Sysmex Corporation and Thermo Fisher Scientific.

Report Coverage:

Report Features Details
Base Year of the Analysis 2023
Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Billion
Segment Coverage Technology, Product, Application, End Use, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Abbott, Becton Dickinson and Company, BioMérieux SA, Danaher Corporation, Merck KGaA, PerkinElmer Inc, Quidel Corporation, Siemens Healthcare Pty Ltd (Siemens AG), Sysmex Corporation and Thermo Fisher Scientific
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 3899
Five User License: US$ 4899
Corporate License: US$ 5899
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Key Questions Answered in This Report:

  • How has the global immunoassay market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global immunoassay market?
  • What are the key regional markets?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end use?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global immunoassay market and who are the key players?
  • What is the degree of competition in the industry?

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Immunoassay Market Report by Technology (Radioimmunoassay, Enzyme Immunoassay, Rapid Test, and Others), Product (Reagents and Kits, Analyzers/Instruments, Software and Services), Application (Therapeutic Drug Monitoring, Oncology, Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, and Others), End Use (Hospitals, Blood Banks, Clinical Laboratories, Pharmaceutical and Biotech Companies, Academic Research Centers, and Others), and Region 2024-2032
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials